BERKELEY, Calif., Nov. 20, 2012 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA) today announced the 837-patient Phase 3 PATH trial (Perindopril Amlodipine for the Treatment of Hypertension) has ...

The study showed that the fixed-dose combination of perindopril arginine with amlodipine besylate as a single pill was significantly better than either compound alone in the reduction of both ...

However, by 4 and 6 months, a higher percentage of patients had a response to treatment in both of the amlodipine-combination groups than in the group that received perindopril plus ...

The participants in the amlodipine-perindopril combination group also experienced a decrease in fasting blood sugar levels after six months. "It was reassuring to find that all three dual ...

CHICAGO, IL—For hypertensive patients, dual-combination therapies taken as a single pill ... to one of three daily single-pill combinations at starting doses: amlodipine plus perindopril, amlodipine ...

NEW ORLEANS, LA—For black patients in sub-Saharan Africa, adding amlodipine to either hydrochlorothiazide (HCTZ) or perindopril is the best way to reduce blood pressure over 6 months, according to ...

In addition, Mr. Emerson and Dr. Feldstein managed the 837-patient Phase 3 PATH trial (Perindopril Amlodipine for the Treatment of Hypertension), which demonstrated that the FDC of perindopril ...

and up to double-digit royalties on sales of a drug containing perindopril arginine and amlodipine besylate, subject to the fixed-dose combination (FDC) being approved by FDA. The FDC is marketed ...

MONTREAL, Feb. 21, 2024 /CNW/ - Pharmascience Canada is proud to announce the launch of pms-PERINDOPRIL ... 18 to 65 for whom combination therapy is appropriate. This oral treatment contains two ...